Literature DB >> 21701430

Alternatives to hysterectomy: focus on global endometrial ablation, uterine fibroid embolization, and magnetic resonance-guided focused ultrasound.

Dale W Stovall1.   

Abstract

The aim of this study was to inform the clinician of alternatives to hysterectomy through a critical evaluation of three treatment options: global endometrial ablation, uterine fibroid embolization, and magnetic resonance-guided focused ultrasound. Studies published in English-language, peer-reviewed journals were systematically searched using Cochrane and Medline. Keywords used included "alternatives to hysterectomy," "endometrial ablation," "uterine fibroid embolization," "uterine artery embolization," and "focused ultrasound." Articles meeting the inclusion criteria were reviewed and analyzed for themes and similarities. All three alternative methods of treatment reviewed are currently approved for use in the United States and abroad. In fact, five different global endometrial ablation devices are approved by the Food and Drug Administration for treatment of menorrhagia. Patient satisfaction scores after endometrial ablation are high (90%-95%), but amenorrhea rates are much lower (15%-60%). Data from randomized trials demonstrate that uterine fibroid embolization results in a shorter hospital stay and quicker return to work as compared with abdominal hysterectomy for leiomyomas, but after embolization, up to 20% of women need a second procedure. Ex-ablative therapy of leiomyomas with focused ultrasound is the newest of the three methods. It has a special set of patient selection criteria and is only available at less than 20 medical centers in the United States. Leiomyoma symptom relief after focused ultrasound therapy at 1 year post-procedure is high (85%-95%). There are many effective alternatives to hysterectomy in women with menorrhagia and/or symptomatic leiomyomas. However, because these procedures are performed by individuals from different subspecialists, primarily gynecologists and interventional radiologists, clinicians must consider using a multidisciplinary approach to find the best procedure for a given patient. There are no randomized trials comparing uterine fibroid embolization to vaginal hysterectomy, laparoscopic hysterectomy, or laparoscopic myomectomy.
© 2011 by The North American Menopause Society

Entities:  

Mesh:

Year:  2011        PMID: 21701430     DOI: 10.1097/gme.0b013e318207fe15

Source DB:  PubMed          Journal:  Menopause        ISSN: 1072-3714            Impact factor:   2.953


  10 in total

1.  Data not correctly calculated.

Authors:  Matthias David; Heribert Kentenich
Journal:  Dtsch Arztebl Int       Date:  2012-03-02       Impact factor: 5.594

2.  High-Intensity Focused Ultrasound Ablation of Uterine Fibroids - Potential Impact on Fertility and Pregnancy Outcome.

Authors:  M K Bohlmann; F Hoellen; P Hunold; M David
Journal:  Geburtshilfe Frauenheilkd       Date:  2014-02       Impact factor: 2.915

Review 3.  Magnetic Resonance-Guided High-Intensity Focused Ultrasound (MRgHIFU) Treatment of Symptomatic Uterine Fibroids: An Evidence-Based Analysis.

Authors:  G Pron
Journal:  Ont Health Technol Assess Ser       Date:  2015-03-01

4.  Halofuginone suppresses growth of human uterine leiomyoma cells in a mouse xenograft model.

Authors:  Faezeh Koohestani; Wenan Qiang; Amy L MacNeill; Stacy A Druschitz; Vanida A Serna; Malavika Adur; Takeshi Kurita; Romana A Nowak
Journal:  Hum Reprod       Date:  2016-04-29       Impact factor: 6.918

5.  Cost effectiveness of endometrial ablation with the NovaSure(®) system versus other global ablation modalities and hysterectomy for treatment of abnormal uterine bleeding: US commercial and Medicaid payer perspectives.

Authors:  Jeffrey D Miller; Gregory M Lenhart; Machaon M Bonafede; Cindy M Basinski; Andrea S Lukes; Kathleen A Troeger
Journal:  Int J Womens Health       Date:  2015-01-06

6.  Cost-Effectiveness of Global Endometrial Ablation vs. Hysterectomy for Treatment of Abnormal Uterine Bleeding: US Commercial and Medicaid Payer Perspectives.

Authors:  Jeffrey D Miller; Gregory M Lenhart; Machaon M Bonafede; Andrea S Lukes; Shannon K Laughlin-Tommaso
Journal:  Popul Health Manag       Date:  2015-02-25       Impact factor: 2.459

7.  Surgical management of neurovascular bundle in uterine fibroid pseudocapsule.

Authors:  Andrea Tinelli; Antonio Malvasi; Brad S Hurst; Daniel A Tsin; Fausto Davila; Guillermo Dominguez; Domenico Dell'edera; Carlo Cavallotti; Roberto Negro; Sarah Gustapane; Chris M Teigland; Liselotte Mettler
Journal:  JSLS       Date:  2012 Jan-Mar       Impact factor: 2.172

8.  Levonorgestrel intrauterine system versus thermal balloon ablation for the treatment of heavy menstrual bleeding: A meta-analysis of randomized controlled trials.

Authors:  Bing-Qing Yang; Jie-Han Xu; Yin-Cheng Teng
Journal:  Exp Ther Med       Date:  2015-09-07       Impact factor: 2.447

9.  Radiofrequency-induced endometrial ablation for the treatment of postpartum hemorrhage after vaginal delivery: Case report.

Authors:  Zhang Wangping; Wu Hanbing
Journal:  Medicine (Baltimore)       Date:  2017-12       Impact factor: 1.889

10.  Significance of changes in inflammatory parameters following uterine artery embolization in pre-menopausal females.

Authors:  Vasileios Souftas; Dorelia Deuteraiou; Xanthoula Anthoulaki; Anna Chalkidou; Anastasia Bothou; Fotini Gaidatzi; Grigorios Tsypsianis; Georgios Iatrakis; Stefanos Zervoudis; Dimitrios Souftas; Spyridon Michalopoulos; Theodosia Vogiatzaki; George Galazios; Nikolaos Nikolettos; Panagiotis Tsikouras
Journal:  Exp Ther Med       Date:  2020-04-09       Impact factor: 2.751

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.